Search

Your search keyword '"Rohan, Thomas E."' showing total 12 results
Start Over Author "Rohan, Thomas E." Journal epidemiology
12 results on '"Rohan, Thomas E."'

5. Abstract 35: Racial disparity in localized breast cancer: Pooled analysis of NSABP trials

Author

Kim, Gina, primary, Pastoriza, Jessica M., additional, Qin, Jiyue, additional, Lin, Juan, additional, Karagiannis, George S., additional, Condeelis, John S., additional, Yothers, Greg, additional, Julian, Thomas B., additional, Anderson, Stewart J., additional, Entenberg, David, additional, Rohan, Thomas E., additional, Sparano, Joseph A., additional, Xue, Xiaonan, additional, and Oktay, Maja H., additional

Published
2021
Full Text
View/download PDF

7. Abstract 4237: Estrogen metabolism in menopausal hormone users: Does it differ between estrogen plus progestin and estrogen alone users in the Women’s Health Initiative Observational Study

Author

Falk, Roni T., primary, Anderson, Garnet L., additional, Barnabei, Vanessa M., additional, Brinton, Louise A., additional, Cauley, Jane A., additional, Chen, Chu, additional, Chlebowski, Rowan T., additional, Coburn, Sally B., additional, Manson, JoAnn E., additional, Pfeiffer, Ruth M., additional, Reding, Kerryn W., additional, Rohan, Thomas E., additional, Sarto, Gloria E., additional, Wentzensen, Nicolas, additional, and Trabert, Britton, additional

Published
2017
Full Text
View/download PDF

8. Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2

Author

Setiawan, Veronica Wendy, primary, Yang, Hannah P., additional, Pike, Malcolm C., additional, McCann, Susan, additional, Yu, Herbert, additional, Xiang, Yong-Bing, additional, Wolk, Alicja, additional, Wentzensen, Nicolas, additional, Weiss, Noel S., additional, Webb, Penelope M., additional, van den Brandt, Piet A., additional, van de Vijver, Koen, additional, Thompson, Pamela J., additional, Strom, Brian L., additional, Spurdle, Amanda B., additional, Shu, Xiao-ou, additional, Schairer, Catherine, additional, Sacerdote, Carlotta, additional, Rohan, Thomas E., additional, Robien, Kim, additional, Risch, Harvey, additional, Ricceri, Fulvio, additional, Rebbeck, Timothy R., additional, Rastogi, Radhai, additional, Prescott, Jennifer, additional, Polidoro, Silvia, additional, Park, Yikyung, additional, Olson, Sara H., additional, Moysich, Kirsten B., additional, Miller, Anthony B., additional, McCullough, Marjorie L., additional, Matsuno, Rayna K., additional, Magliocco, Anthony M., additional, Lurie, Galina, additional, Lu, Lingeng, additional, Lissowska, Jolanta, additional, Liang, Xiaolin, additional, Lacey, James V., additional, Kolonel, Laurence N., additional, Henderson, Brian E., additional, Hankinson, Susan E., additional, Håkansson, Niclas, additional, Goodman, Marc T., additional, Gaudet, Mia M., additional, Garcia-Closas, Montserrat, additional, Friedenreich, Christine, additional, Freudenheim, Jo L., additional, and Doherty, Jennifer, additional

Published
2012
Full Text
View/download PDF

11. Agreement of SelfReported Use of Menopausal Hormone Replacement Therapy with Physician Reports

Author

Jain, Meera G., Rohan, Thomas E., and Howe, Geoffrey R.

Abstract

There have been relatively few epidemiological studies to verify the information obtained from study participants on the use of menopausal hormone replacement therapy. We conducted this study as part of a case-control study of diet, hormone use, and endometrial cancer in Toronto, Ontario, Canada, 1994–1998. We compared records from 653 subjects, 30–79 years of age, with reports from their physicians on ever/never use of hormone replacement therapy and duration, type, and dose of hormone replacement therapy. A total of 88 of the interview records were in agreement with physician reports for ever/never use of hormone replacement therapy. The overall kappa value for ever/never use agreement was 0.76 (range = 0.71–0.81), and the intraclass correlation coefficient was 0.64 (range = 0.57–0.70) for duration of hormone replacement therapy use, indicating good agreement; similar correlations were seen among cases and controls for overall use, as well as estrogen- or progestogen-alone use. Concordance for brand codes was observed for about 43 of the subjects. This study suggests that information obtained by interview in case-control studies provides a reasonable measure of ever use of hormone replacement therapy and duration of use. Interviews, however, do not represent a reliable source of information on brands and dosage of hormone replacement therapy preparations. (Epidemiology 1999;10:260–263)

Published
1999

12. Repeatability of InterviewDerived Information on Sexual History

Author

Rohan, Thomas E., McLaughlin, John R., and Harnish, Delsworth G.

Abstract

We assessed the repeatability of interview-derived information on age at first sexual intercourse and number of sexual partners in women participating in an ongoing prospective study of genital human papillomavirus infection in Toronto, Canada. Of the 100 study participants invited to attend for re-interview twice during their first year in the study, 74 attended for the first follow-up interview about 5 months after recruitment, and 28 of these 74 subjects attended for a second interview about 4 months later. For both age at first sexual intercourse and number of sexual partners, intraclass correlation coefficients were high, ranging from 0.94 to 0.98. Repeatability differed a little by human papillomavirus status, but not by levels of other relevant factors.

Published
1994

Catalog

Books, media, physical & digital resources
See catalog results